The goals of the Laboratory Cancer Research Center are to: (a) foster research in chemical carcinogenesis, particularly as it relates to nitrogen-containing organic compounds, certain chemotherapeutic agents and polycyclic aromatic hydrocarbons, (b) develop model systems for the study of the counterparts to human colon, pancreas, esophagus, prostate and lung cancers, (c) develop an understanding of the mechanisms of activation of procarcinogens and of detoxification of carcinogens and to elucidate the contributions of nutrition, environment and genetics to their regulation, (d) clarify the role of DNA repair in mutagenesis and carcinogenesis, (e) elucidate the mechanisms by which certain viruses are able to transform cells, as well as how chemical carcinogens may influence this expression, (f) develop a program in clinical and biochemical epidemiology and (g) extrapolate from the accomplishment of the above aims to understanding the human cancer problem. These areas are being met by a team of pathologists, virologists, nutritionists, pharmacologists, chemists, biochemists and cell/molecular biologists working in a collaborative manner. The cancer center is augmented by educational efforts aimed primarily at the graduate level, but also reflected in undergraduate medical and postgraduate programs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA036727-07
Application #
3101785
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1984-07-01
Project End
1992-06-30
Budget Start
1990-07-16
Budget End
1991-06-30
Support Year
7
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Type
Schools of Medicine
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68198
Cserhati, Matyas F; Mooter, Mary-Ellen; Peterson, Lauren et al. (2018) Motifome comparison between modern human, Neanderthal and Denisovan. BMC Genomics 19:472
Barkeer, Srikanth; Chugh, Seema; Karmakar, Saswati et al. (2018) Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells. BMC Cancer 18:1157
Luan, Haitao; Mohapatra, Bhopal; Bielecki, Timothy A et al. (2018) Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program. Cancer Res 78:2524-2535
Napon, Geoffroy; Dafferner, Alicia J; Saxena, Ashima et al. (2018) Identification of Carboxylesterase, Butyrylcholinesterase, Acetylcholinesterase, Paraoxonase, and Albumin Pseudoesterase in Guinea Pig Plasma through Nondenaturing Gel Electrophoresis. Comp Med 68:367-374
Azadmanesh, Jahaun; Borgstahl, Gloria E O (2018) A Review of the Catalytic Mechanism of Human Manganese Superoxide Dismutase. Antioxidants (Basel) 7:
Rana, Sandeep; Sonawane, Yogesh A; Taylor, Margaret A et al. (2018) Synthesis of aminopyrazole analogs and their evaluation as CDK inhibitors for cancer therapy. Bioorg Med Chem Lett 28:3736-3740
Chhonker, Yashpal S; Haney, Staci L; Matthiesen, Robert A et al. (2018) Quantitative determination of a potent geranylgeranyl diphosphate synthase inhibitor using LC-MS/MS: Derivatization and application. J Pharm Biomed Anal 153:22-28
Haney, Staci L; Chhonker, Yashpal S; Varney, Michelle L et al. (2018) Preclinical investigation of a potent geranylgeranyl diphosphate synthase inhibitor. Invest New Drugs 36:810-818
Saxena, Sugandha; Hayashi, Yuri; Wu, Lingyun et al. (2018) Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis. Oncotarget 9:5931-5943
Lockridge, Oksana; David, Emilie; Schopfer, Lawrence M et al. (2018) Purification of recombinant human butyrylcholinesterase on Hupresin®. J Chromatogr B Analyt Technol Biomed Life Sci 1102-1103:109-115

Showing the most recent 10 out of 1372 publications